Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 4500 results
Duchesnay introduces Diclegis in US market
23 May 2013 | By PBR Staff Writer
Duchesnay USA has announced the availability of Diclegis, a composition of 10mg doxylamine succinate and 10mg pyridoxine hydrochloride (vitamin B6), in US pharmacies.
Drug Research > Drug Discovery & Development > News
Liquidia extends collaboration with PATH to develop Pneumococcal vaccine
22 May 2013 | By PBR Staff Writer
Liquidia, the designer and manufacturer of engineered particles, has announced that its collaboration with PATH has been extended to develop next generation Pneumococcal vaccine.
Drug Research > Drug Discovery & Development > News
Impax introduces authorized generic of Zomig in US
20 May 2013 | By PBR Staff Writer
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News
AbbVie, Galapagos extend GLPG0634 agreement to include Crohn's disease
20 May 2013 | By PBR Staff Writer
Galapagos and AbbVie have extended their GLPG0634 clinical development collaboration to include Crohn's disease.
Drug Research > Drug Discovery & Development > News
Almac secures BBSRC programme with UCL
17 May 2013 | By PBR Staff Writer
UK-based Almac biocatalysis has secured a Biotechnology and Biological Sciences Research Council (BBSRC) programme with University College London (UCL) aimed at metagenomics and novel enzyme discovery.
Drug Research > Drug Discovery & Development > News
Evotec, Harvard to jointly develop new class of antibacterials
17 May 2013 | By PBR Staff Writer
Evotec and Harvard University have entered into research collaboration to develop new class of antibacterials.
Drug Research > Drug Discovery & Development > News
BioDuro opens laboratory in China
17 May 2013 | By PBR Staff Writer
BioDuro has opened a new laboratory in Shanghai to supply customized drug discovery services to biopharmaceutical clients in Asia Pacific.
Drug Research > Drug Discovery & Development > News
Mylan introduces generic version of Abbvie Tricor tablets
17 May 2013 | By PBR Staff Writer
Mylan Pharmaceuticals, the subsidiary of Mylan, has introduced Fenofibrate tablets, 48 mg and 145 mg.
Drug Research > Drug Discovery & Development > News
India develops new low-cost vaccine against diarrhea virus
15 May 2013 | By PBR Staff Writer
The Indian government has announced the development of new low-cost vaccine referred to as Rotavac against rotavirus, a diarrhea causative agent leading to a number of childhood deaths in the developing world.
Drug Research > Drug Discovery & Development > News
BioTrinity 2013 - European Biopartnering and Investment Conference - May 14-16, 2013
13 May 2013
BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other European partnering conference. Check out who else is coming, we expect about 850 delegates including nearly 80 investment firms, hear what delegates say about BioTrinity, the expert discussion panels, and which 90 companies will be presenting in the showcase.
Drug Research > Drug Discovery & Development > Press Releases
ALS-ETF, Denovo partner for Amyotrophic Lateral Sclerosis treatment
13 May 2013 | By PBR Staff Writer
The ALS Emergency Treatment Fund (ALS-ETF) and Denovo Biomarkers (Denovo) have entered into partnership to explore using Denovo's technology to identify potential responder groups for drugs that are being studied in patients suffering from Amyotrophic Lateral Sclerosis (ALS).
Drug Research > Drug Discovery & Development > News
Nimbus, Shire enter into co-development agreement for lysosomal storage disorders
10 May 2013 | By PBR Staff Writer
Nimbus Discovery, a US-based biotechnology company, has entered into a co-development agreement with Shire aiming at small molecule treatments for lysosomal storage disorders (LSDs), which are considered as the rare genetic diseases.
Drug Research > Drug Discovery & Development > News
GlaxoSmithKline Pharmaceuticals Q1 net income increases
08 May 2013 | By PBR Staff Writer
GlaxoSmithKline Pharmaceuticals in India has reported a net income from operations of Rs6.37bn ($118.06m) for the first quarter ended 31 March 2013 compared to Rs6.28bn ($116.39m) for the first quarter ended 31 March 2012.
Drug Research > Drug Discovery & Development > News
Ablynx commences pre-clinical development of allergic asthma candidate
08 May 2013 | By PBR Staff Writer
Ablynx has commenced pre-clinical development of ALX-0962, an anti- immunoglobulin E (IgE) nanobody, to treat severe allergic asthma and expects to begin Phase I development in the second half of 2014.
Drug Research > Drug Discovery & Development > News
Redx Pharma to open new R&D center in UK
08 May 2013 | By PBR Staff Writer
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Polygon Medical Animation - 3D Medical Animation, Illustration and Interactive
Polygon is the full-service global provider of high-end MOA mechanism of action 3D medical animation and Illustration for the Pharma and Biotech industry, as well as educational institutes worldwide. ... Drug Research > Drug Discovery & Development > Suppliers
Chemoswed - When Good Enough Isn't
Chemoswed is the reliable Swedish custom synthesis specialist, supplying active ingredients since 1944. With a background in Pharmacia, Chemoswed is since 1996 an independent entity within the DuPont group, offering cost-effective, turn-key solutions to API needs worldwide.We have established unparalleled experience and technology, enabling efficient development and production of quality active pharmaceutical ingredients in quantities from 100 grams to 50 tons.... Drug Research > Drug Discovery & Development > Suppliers
Atlantic Research Chemicals - Your Partner in Building Block Supply
Founded with over 20 combined years of experience within the drug discovery market, Atlantic Research Chemicals aims to offer the most select, diverse and unique products available within the drug discovery business sector.... Drug Research > Drug Discovery & Development > Suppliers
VERTIS Biotechnologie - Next Generation RNA Sequencing & Gene Regulation Analyses
VERTIS is a privately owned research organisation with a focus on Next Generation Sequencing (NGS) especially on transcriptome sequencing (RNA-seq). It was founded in 2000 as a spin-off from the Technische Universität München (TUM) - Weihenstephan. The company offers a complete product line, ranging from project consulting, nucleic acid isolation, sample preparation and DNA sequencing to bioinformatic sequence analysis and data mining.... Drug Research > Drug Discovery & Development > Suppliers
EMCM - Supporting Opportunities
Founded in 1993, European Medical Contract Manufacturing (EMCM) has grown to a centre of excellence in developing and manufacturing sterile medicinal products in GMP & ISO accredited facilities. These products are used in Biomaterials, Pharmaceuticals and Tissue Engineering specialties conforming to the standards of the USFDA, EMEA & ISO.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

The Emergence of Real-Time Intelligence to Overcome Limits of Traditional Biopharma Market Research 21 March 2013 | By BioPharm Insight PBR
With heightened competition throughout the global biopharma landscape, the demand for business intelligence (BI) has intensified – as has the need for new tools and information to provide BI departments with an actionable edge. This white paper outlines innovative new methods being used by BI thought leaders to achieve that elusive edge. ... Drug Research > Drug Discovery & Development > White Papers Seven Proven Strategies to Choose Better Investigators 21 March 2013 | By BioPharm Insight PBR
The global biopharmaceutical industry is in a state of flux. As the costs of drug development and the risks of failure continue to escalate, companies are facing a fundamental imperative: the current model of bringing new drugs to market must change. Read this white paper to learn eight strategies used by successful business development professionals to sell their services to pharma, from tracking drugs changing phase and monitoring new financing to identifying decision-making contacts.... Drug Research > Drug Discovery & Development > White Papers TM-II Tool Management Systems 13 February 2013 | By Natoli Engineering Company
Natoli's Tool Management II (TM-II) system is the most efficient software available to manage your entire tool database. Designed to help tablet manufacturers improve product quality and consistency, TM-II organizes critical punch inspection dimensions through a user-friendly, comprehensive tooling database.... Drug Research > Drug Discovery & Development > White Papers Natoli Tooling Storage Box 13 February 2013 | By Natoli Engineering Company
Natoli Engineering’s toolboxes were designed to provide additional storage and maintenance support for tablet compression tooling.... Drug Research > Drug Discovery & Development > White Papers Tablet Compression Accessories Catalogue 13 February 2013 | By Natoli Engineering Company
At Natoli Engineering, no steel is cut until it is confirmed to meet our stringent steel quality specifications. Our steel is quarantined and tested according to guidelines governed by the American Society for Testing & Materials. We take pride in offering steel of the highest quality and consistency and we have the test results to prove it. ... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 4500 results